TAVI in 2025: transforming care with the new valvular heart disease guidelines
Sponsored by Edwards Lifesciences
TAVI
Symposium with LIVE case
Edwards Lifesciences
Main Arena
Anchorperson: Christopher Cook
Spokesperson: Martin Leon
Operators: Sabine Bleiziffer, Tanja Rudolph
Procedural Analyst: Radoslaw Parma
Discussants: Philippe Genereux, Kentaro Hayashida, Philippe Pibarot, Ferdinand Vogt
Onstage Medical Coordinator: Omar Chehab
Cathlab Medical Coordinator: Mohammad Kassar
Watch this session if you want
- To understand how the 2025 valvular heart disease guidelines are reshaping TAVI care and clinical decision-making
- To engage with the paradigm shift in the contemporary management of severe aortic stenosis
- To gain a global perspective on addressing the challenges of an expanding TAVI population
Welcome and session objectives
Christopher Cook
Patient presentation and headline updates from VHD guidelines
Philippe Genereux
Heart team discussion
LIVE Case procedure
Case debrief
Procedural analysis
Radoslaw Parma
Discussion and audience interaction
International multidisciplinary perspective on early referral, simplified evaluation, and prompt treatment of patients with aortic stenosis
Philippe Pibarot
Discussion and audience interaction
Session evaluation and key learnings